4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000191
Chairperson & CEO sold 9,500 shares at an average $580.43 ($5,514,046)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-11-17 | Sale : show line 2 in the form 10b5-1 | −373 | $576.16 | $214,909 | 333,570 | I |
| 2026-11-17 | Sale : show line 3 in the form 10b5-1 | −1,017 | $577.14 | $586,950 | 332,553 | I |
| 2026-11-17 | Sale : show line 4 in the form 10b5-1 | −1,763 | $578.17 | $1,019,319 | 330,790 | I |
| 2026-11-17 | Sale : show line 5 in the form 10b5-1 | −1,127 | $579.11 | $652,655 | 329,663 | I |
| 2026-11-17 | Sale : show line 6 in the form 10b5-1 | −955 | $580.13 | $554,026 | 328,708 | I |
| 2026-11-17 | Sale : show line 7 in the form 10b5-1 | −1,112 | $581.18 | $646,270 | 327,596 | I |
| 2026-11-17 | Sale : show line 8 in the form 10b5-1 | −449 | $582.57 | $261,576 | 327,147 | I |
| Open-market sales · 9,500 sh · avg $580.43 · $5,514,046 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2026-11-17 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option | −9,500 | $117.76 | 2027-03-15 | 9,500 | 5,410 | I |
Loading xslF345X06/primarydocument.xml…